Attune Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Attune Pharmaceuticals has a total of 24 patents globally, out of which 12 have been granted. Of these 24 patents, more than 37% patents are active. The United States of America is where Attune Pharmaceuticals has filed the maximum number of patents, followed by Europe, Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Attune Pharmaceuticals.

Attune Pharmaceuticals was founded in 2018. Attune Pharmaceuticals is a biotechnology company. The company creates innovative oral small molecule medicines for treating uncommon diseases.

Do read about some of the most popular patents of Attune Pharmaceuticals which have been covered by us in this article and also you can find Attune Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Attune Pharmaceuticals patent portfolio.

How Many Patents did Attune Pharmaceuticals File Every Year?

Attune Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAttune Pharmaceuticals Applications FiledAttune Pharmaceuticals Patents Granted
202114
202012
201984
201821
201711
20165
20155
20141

How many Attune Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Attune Pharmaceuticals Patent Portfolio

How Many Patents did Attune Pharmaceuticals File in Different Countries?

Attune Pharmaceuticals Worldwide Patent Filing

Countries in which Attune Pharmaceuticals Filed Patents

CountryPatent
United States Of America14
Europe2
Australia2
Canada2
Hong Kong (S.A.R.)1
Germany1
Austria1
China1

Where are Research Centers of Attune Pharmaceuticals Patents Located?

The Research Centers of Attune Pharmaceuticals Patents is the United States of America.

10 Best Attune Pharmaceuticals Patents

US9611252B2 is the most popular patent in the Attune Pharmaceuticals portfolio. It has received 9 citations so far from companies like Lifesci Pharmaceuticals, Janssen Pharmaceutica.

Below is the list of 10 most cited patents of Attune Pharmaceuticals:

Publication NumberCitation Count
US9611252B29
US10023557B26
US10301284B25
US10259803B24
US20190127366A14
US10781200B23
US10266515B23
US10308637B22
US20200031799A11
US20190263818A11

What Percentage of Attune Pharmaceuticals US Patent Applications Were Granted?

Attune Pharmaceuticals (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 69.23%.

Below are the key stats of Attune Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Attune Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Wilson Sonsini Goodrich & Rosati1369.23%

List of Attune Pharmaceuticals patents

Attune Pharmaceuticals PatentsTitle
US11021463B2Therapeutic Inhibitory Compounds
US10981893B2Therapeutic Inhibitory Compounds
US10781200B2Therapeutic Inhibitory Compounds
US9611252B2Therapeutic Inhibitory Compounds
EP3169325B1Therapeutic Inhibitory Compounds
CN112770751ATreatment Of Hereditary Angioedema
CA2954814A1Isonicotinamide Compounds And Their Use As Plasma Kallikrein Inhibitors
CA3092538A1Treatment Of Hereditary Angioedema
HK40041266ATreatment Of Hereditary Angioedema
US10308637B2Therapeutic Inhibitory Compounds
US10301284B2Therapeutic Inhibitory Compounds
US10266515B2Therapeutic Inhibitory Compounds
US10259803B2Therapeutic Inhibitory Compounds
US10023557B2Therapeutic Inhibitory Compounds
US20210395221A1Therapeutic Inhibitory Compounds
US20200031799A1Therapeutic Inhibitory Compounds
US20190263818A1Therapeutic Inhibitory Compounds
US20190127366A1Therapeutic Inhibitory Compounds
US20200405708A1Treatment Of Hereditary Angioedema
EP3758702A4Treatment Of Hereditary Angioedema
AU2015289643B2Therapeutic Inhibitory Compounds
AU2019227866A1Treatment Of Hereditary Angioedema
DE602015068752T2Therapeutic Inhibitoring Compounds
AT1386924TTherapeutische Hemmende Verbindungen

What are Attune Pharmaceuticals key innovation segments?

What Technologies are Covered by Attune Pharmaceuticals?

The chart below distributes patents filed by Attune Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Attune Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Attune Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Attune Pharmaceuticals?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.